Blood glucose test strips are small, disposable plastic or paper strips used to measure blood glucose levels and manage diabetes symptoms. They are made from polyolefin, polyamide, polysulfone, and cellulose. A blood glucose test strip is made up of various components, including hydrophilic, adhesive, sensors, enzymes, and electrode layers. They are also soaked in glucose oxidase, which interacts with the glucose in the blood sample to determine sugar levels. Aside from that, blood glucose test strips are simple to use, inexpensive, and can be used everyday. As a result, they help identify high or low blood sugar levels, track the efficacy of diabetes treatment, and reduce the risk of developing hypoglycemia and/or hyperglycemia.
Europe Blood Glucose Test Strips Market Driving Factors and Challenges
The rising prevalence of diabetes, particularly among the expanding elderly demographic, is fostering a favorable market landscape. Blood glucose test strips are widely utilized for convenient at-home sugar level monitoring, obviating the need for diagnostic laboratory visits, thus fueling market expansion. Moreover, the ease of glucometer availability, user-friendly handling, and machine accuracy are driving product adoption among type-2 diabetic patients. During the COVID-19 pandemic, there was a notable uptick in demand and online sales for blood glucose monitoring devices and consumables. This surge is attributed to the heightened necessity for continuous sugar level monitoring, both as a precautionary measure and for post-infection symptom tracking. Furthermore, factors such as intensive research and development in biomedical engineering, shifting lifestyles and dietary patterns, and government initiatives aimed at diabetes education and prevention are poised to propel market growth.
In the Europe blood glucose test strips market, several challenges persist. Intense price competition among market players striving to offer affordable test strips not only impacts profit margins but also hampers investment in research and development. Stringent regulatory requirements for medical devices pose hurdles for manufacturers, hindering compliance and market entry. Economic uncertainties, varying healthcare budgets, and reimbursement issues across European countries may limit patient access to blood glucose test strips due to affordability concerns. Additionally, the increasing adoption of alternative monitoring technologies, such as continuous glucose monitoring systems and non-invasive glucose monitoring technologies, poses a threat to the traditional test strip market, requiring adaptation strategies from manufacturers to remain competitive in the evolving landscape.
Impact of COVID-19 on Europe Blood Glucose Test Strips Market
The COVID-19 epidemic has had a huge influence on the European blood glucose test strips industry. Lockdown measures and disruptions in healthcare facilities have resulted in delays in routine check-ups and diagnoses, reducing demand for blood glucose test strips. Furthermore, economic uncertainty has resulted in decreased disposable income and healthcare spending among consumers. However, the rising emphasis on remote monitoring and telehealth options has helped to alleviate the drop in demand, with some patients opting for home glucose monitoring. Throughout the epidemic, the market has faced both problems and possibilities.
Europe Blood Glucose Test Strips Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Abbott, Agamatrix Inc., Acon, Arkray, Ascensia Diabetes Care, Bionime Corporation, Dexcom, F. Hoffmann-La Roche AG, Johnson & Johnson, Medisana, Medtronic, Rossmax, Trivida, Others.
Europe Blood Glucose Test Strips Market Segmentation:
By Type: Based on the Type, Europe Blood Glucose Test Strips Market is segmented as; Optical Strips, Thick Film Electrochemical Films, Thin Film Electrochemical Films.
By Technology: Based on the Technology, Europe Blood Glucose Test Strips Market is segmented as: Glucose Dehydrogenase, Glucose Oxidase.
By End User: Based on the End User, Europe Blood Glucose Test Strips Market is segmented as; Diagnostic Laboratories, Home Care, Hospitals.
By Region: This research also includes data for Belgium, France, Germany, Italy, Netherlands, Russia, Spain, Switzerland, The U.K., Turkey, Rest of Europe.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.